Quite a diversity of topics this week, as Gary, Henry, Kate and Mark talk about: CV risk with triptans, baseline urate levels and risk of acute flairs in adults with gout, primary care feasible tests for acute diverticulitis, and how APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease.

Quite a diversity of topics this week, as Gary, Henry, Kate and Mark talk about: CV risk with triptans, baseline urate levels and risk of acute flairs in adults with gout, primary care feasible tests for acute diverticulitis, and how APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease.

Episode 154: triptans and CV risk, urate levels and flares, tests for acute diverticulitis, and APOE4

Four healthily skeptical primary care physicians discuss the latest in primary care medicine. Join Essential Evidence Editor Mark Ebell MD, Rush University's Kate Rowland MD, MSU Professor of Medicine Gary Ferenchick MD, and POEMs co-founder Henry Barry MD, MS for this fast-paced weekly update on evidence-based primary care.

Share Episode 154: triptans and CV risk, urate levels and flares, tests for acute diverticulitis, and APOE4

Sign up to save your podcasts

Episode 154: triptans and CV risk, urate levels and flares, tests for acute diverticulitis, and APOE4

Episode 154: triptans and CV risk, urate levels and flares, tests for acute diverticulitis, and APOE4